APA Citatie

Swords, R. T., Watts, J., Erba, H. P., Altman, J. K., Maris, M., Anwer, F., . . . DeAngelo, D. J. (2017). Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes. Blood Cancer J.

Chicago Style citaat

Swords, R T., et al. "Expanded Safety Analysis of Pevonedistat, a First-in-class NEDD8-activating Enzyme Inhibitor, in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes." Blood Cancer J 2017.

MLA citatie

Swords, R T., et al. "Expanded Safety Analysis of Pevonedistat, a First-in-class NEDD8-activating Enzyme Inhibitor, in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes." Blood Cancer J 2017.